Biotech is noisy.

Every day brings new press releases, optimistic slides, sponsored “insights,” and confident predictions that rarely age well. Important signals are buried under incentives that reward attention, not accuracy.

BioCatalyst Brief exists to reduce that noise.

This publication is not here to promote companies, sell narratives, or chase momentum. It is here to analyze biotech, life sciences, and applied AI with one goal: clarity.

What we will do:
– Evidence-based breakdowns of biotech and life-science news

– Practical perspectives on applied AI in R&D and industry

– Market and product thinking (without “storytelling for investors”)

– Clear, readable conclusions and explicit assumptions

Principles:
– Independent first: no paid promotions disguised as analysis

– Clarity over complexity: plain language when possible

– Uncertainty is allowed: facts, interpretation, and speculation are separated

– Time is scarce: we optimize for insight per minute